Trade Bristol Myers BMY

BristolMyers live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

BristolMyers News

Julian Parker 2026 Jun 17, 16:02

FOMC June 2026: Warsh’s Hawkish Pivot and Forex Market Impact

forex
Julian Parker 2026 Jun 17, 16:01

SpaceX Stock Forecast 2027, 2031 and 2036: What the Lockup Schedule Means for SPCX Shares

stocks
Julian Parker 2026 Jun 16, 16:03

USD/CAD Forecast: Oil Weakness Keeps 1.4000 in Focus

forex
Julian Parker 2026 Jun 16, 16:01

Bitcoin and the Fed’s Guidance Shift: Short-Term Risk, Long-Term Narrative

crypto
Julian Parker 2026 Jun 16, 16:01

Japan and South Korea Stocks Rebound as Nikkei Hits Fresh High and KOSPI Rises Over 1.5%

indices
Julian Parker 2026 Jun 15, 16:02

Silver Price Forecast: XAG/USD Holds Below $70 as Fed Decision Shapes Outlook

commodity
Julian Parker 2026 Jun 15, 16:01

EUR/USD Outlook: Dollar Firms Before Fed Decision as Euro Rally Loses Momentum

forex
Julian Parker 2026 Jun 14, 16:05

5 Ways South African Traders Can Capitalise on the SpaceX Listing Aftermath

cfd trading stocks
Julian Parker 2026 Jun 14, 16:02

How to Trade the SpaceX (SPCX) IPO Surge From South Africa With CFDs — Without Owning a Single Share

stocks
Julian Parker 2026 Jun 10, 16:01

SpaceX IPO Puts S&P 500 Inclusion Question in Focus

stocks

Latest news

Show more
Julian Parker 2026 Jun 17, 16:05

Today's Stock Prices: U.S. Stocks Fall, SpaceX Slides, Allbirds Soars 39%

Stock
Julian Parker 2026 Jun 17, 16:04

Gold Price Today, June 18, 2026: Spot Gold Slides Toward $4,250 as Fed Signals Possible 2026 Rate Hike

gold price today
Julian Parker 2026 Jun 17, 16:04

Brent Oil Price Today: Brent Falls Below $79 as US-Iran Peace Deal Drains War Premium

Commodities
Julian Parker 2026 Jun 17, 16:02

Kevin Warsh’s First Fed Decision Turns Hawkish as Dot Plot Revives 2026 Rate Hike Bets

Forex
Julian Parker 2026 Jun 16, 16:05

Gold Price Today, June 17, 2026: Gold Holds Near One-Week High as Oil Slump Eases Fed Rate-Hike Fears

gold price today
Julian Parker 2026 Jun 16, 16:02

Brent Crude Falls Below $80 as Goldman Sachs and Morgan Stanley Cut Oil Forecasts

Commodities
Julian Parker 2026 Jun 16, 16:01

SpaceX Stock Rally Extends as Options Debut Fuels Post-IPO Surge

Stock
Julian Parker 2026 Jun 15, 16:04

Bank of Japan Raises Interest Rate to 1% as Yen Pressure Persists

Forex

Info

Spread

0.33

Spread (%)

0.6117 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

110271848448

Shares Outstanding

2042071247

Earnings Date (Next)

2001-08-07

Div Yield

2026-08-03

Ex-Dividend Date

2026-07-02

Forward annual dividend rate

2.52

Forward annual dividend yield

0.0467

EPS

3.57

Learn more about this instrument

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience. The company's products include Opdivo for various anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumorsr; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of unresectable or metastatic melanoma; Reblozyl to treat anemia; Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Opdualag for the treatment of unresectable or metastatic melanoma; and Camzyos to treat symptomatic obstructive HCM. It also offers Zeposia to treat relapsing forms of multiple sclerosis; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Krazati for the treatment of KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); and Cobenfy to treat schizophrenia. In addition, it offers Eliquis for a reduction in risk of stroke/systemic embolism and for the treatment of DVT/PE; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; Pomalyst/Imnovid for multiple myeloma; Sprycel for Philadelphia chromosome-positive chronic myeloid leukemia; and Abraxane for the treatment of breast cancer. Further, it provides Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; and NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, specialty pharmacies, retailers, hospitals, clinics, and government agencies. Bristol-Myers Squibb Company has a strategic collaboration with Arcus Biosciences, Inc. to develop a novel treatment regimen that delivers tumor control in kidney cancer. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in Princeton, New Jersey.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Julian Parker 2026 Jun 17, 16:03

How to Open a Swap-Free Account: Full Step-by-Step Guide

Julian Parker 2026 Jun 17, 16:01

Is Forex & CFD Trading Halal? The Ultimate Guide to Islamic Trading Account

Julian Parker 2026 Jun 16, 16:04

High-Leverage Forex Brokers: What Traders Need to Know Before Using High Leverage

Trustpilot